Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/1996
03/20/1996EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent
03/20/1996EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
03/20/1996EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
03/20/1996EP0701568A1 New peptide derivatives
03/20/1996EP0701555A1 Indazole derivatives
03/20/1996EP0701546A1 Aromatic acetylcholinesterase inhibitors
03/20/1996EP0701450A1 Recombinant viruses and their use in gene therapy
03/20/1996EP0701444A1 Methods and compositions for inducing sleep
03/20/1996EP0701441A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
03/20/1996EP0659083A4 Prevention and treatment of peripheral neuropathy.
03/20/1996EP0656776B1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt
03/20/1996EP0556332B1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
03/20/1996EP0505465B1 4-Heterocyclyl-piperidine derivatives, their preparation and their use as inhibitors of calcium overload in brain cells
03/20/1996CN1119014A Benzopyranes as potassium channel openers
03/20/1996CN1118989A Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
03/20/1996CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines
03/20/1996CN1118694A Ginseng candy for abstention from smoking
03/19/1996US5500443 New benzodioxane compounds
03/19/1996US5500442 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
03/19/1996US5500428 Furyl-substituted purines and adenosine antagonists
03/19/1996US5500425 Chroman derivatives and a method of treating 5-HT mediated disorders
03/19/1996US5500423 Analgesics
03/19/1996US5500420 Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
03/19/1996US5500418 Antiepileptic
03/19/1996US5500226 Pharmaceutical composition having analgesic activity
03/19/1996US5500222 Mixed with monoglyceride permeation enhancer
03/19/1996CA2014208C Selective blocking of spontaneously-active dopamine neurones in ventral tegmental area
03/16/1996CA2158225A1 Imidazopyridines
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007665A1 Anthracycline derivatives
03/14/1996WO1996007653A1 Endothelin receptor antagonists
03/14/1996WO1996007651A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/14/1996WO1996007649A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996WO1996007641A1 Heterocyclic derivative and medicine
03/14/1996WO1996007637A1 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
03/14/1996WO1996007425A1 Method of blocking the sec receptor
03/14/1996WO1996007412A1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
03/14/1996WO1996007405A1 Excitatory amino acid receptor antagonists
03/14/1996WO1995034651A3 Corticotropin-releasing factor2 receptors
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2199518A1 Heterocyclic derivative and medicine
03/14/1996CA2199508A1 Excitatory amino acid receptor antagonists
03/14/1996CA2199180A1 Method of blocking the sec receptor
03/14/1996CA2198477A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996CA2197463A1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
03/13/1996EP0700913A1 5,6-dihydro-4H-imidazo(4,5,1-ij)quinolines, processes for their preparation, their use as medicaments, and intermediate compounds
03/13/1996EP0700906A1 Heterocyclic derivatives of N-phenylamides
03/13/1996EP0700905A1 Tricyclic pyrazole derivatives
03/13/1996EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them
03/13/1996EP0700680A1 Gepirone dosage form
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700398A1 Psoralen derivatives, their preparation and use as medicaments
03/13/1996EP0700387A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
03/13/1996EP0700383A1 Novel 1-phenylalkanone 5-ht 4? receptor ligands
03/13/1996EP0700378A1 Compounds which release nitric oxide
03/13/1996EP0700296A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
03/13/1996EP0700290A1 Rectal compositions
03/13/1996EP0700289A1 Antidepressant dosage form
03/13/1996EP0700286A1 Apoptosis inhibitors for treating neurodegenerative diseases
03/13/1996EP0544880B1 Method of preparing diacetyl rhein
03/13/1996EP0455783B1 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
03/13/1996CN1118599A Xanthine derivatives as adenosine A1 receptor antagonists
03/13/1996CN1118598A Pyrrolo-pyridine derivatives
03/13/1996CN1118347A Benzotoudened 5-ringneterocycl, preparation and phamaceutical and diagnostic use of same
03/13/1996CN1118258A Preparation of brain-care pill
03/13/1996CN1031267C Compounds for anti-dementia medicine and its usage
03/13/1996CA2157998A1 Pharmaceutical compounds
03/12/1996US5498726 Preparation of physostigmine carbamate derivatives from physostigmine
03/12/1996US5498722 Hypotensives
03/12/1996US5498628 Naphthamide derivatives
03/12/1996US5498626 Acylaminoindole derivatives as 5-ht1 agonists
03/12/1996US5498623 4(5) substituted imidazoles and their preparation and use
03/12/1996US5498618 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides for treating smooth muscle contraction disorders
03/12/1996US5498614 Bridged aza-bicyclic derivatives as substance P antagonist
03/12/1996CA2046943C Process for producing an agent with the active substance flupirtine to combat muscular tension
03/12/1996CA2016182C Heterocyclicguanidines as 5ht- antagonists
03/07/1996WO1996007096A1 AN IN VITRO SYSTEM FOR DETERMINING FORMATION OF Aβ AMYLOID
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006862A1 Gabaa receptor epsilon subunit
03/07/1996WO1996006859A1 Trophic factors for central nervous system regeneration
03/07/1996WO1996006855A1 NEW PEPTIDE DERIVATIVES WITH δ OPIOID RECEPTOR ANTAGONIST OR MIXED ν AGONIST/δ ANTAGONIST EFFECTS
03/07/1996WO1996006845A1 Substituted 9-alkyladenines
03/07/1996WO1996006842A1 Salts of an anti-migraine indole derivative
03/07/1996WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996WO1996006837A1 Isoxazoles
03/07/1996WO1996006821A1 Neurotrophic and antiproliferative compounds
03/07/1996WO1996006630A1 Methods and compositions for modulating a t cell response
03/07/1996WO1996006626A1 Analgesic method with dynorphin analogues truncated at the n-terminus
03/07/1996WO1996006618A1 Cosolvent parenteral formulation of tirilazad
03/07/1996WO1996006610A1 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
03/07/1996WO1996006606A1 Dihydro-2,3-benzodiazepine derivatives
03/07/1996DE4430639A1 Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten Use of 5-substituted pyridine and hexahydroquinoline-3-carboxylic acid derivatives
03/07/1996CA2198891A1 Genetically modified t cells
03/07/1996CA2198728A1 Neurotrophic and antiproliferative compounds
03/07/1996CA2198587A1 Trophic factors for central nervous system regeneration
03/07/1996CA2198495A1 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
1 ... 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 ... 1833